Oncobiotek Drugs Private Limited, a active private limited company, was established on 03 July 2014 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24230GJ2014PTC079996. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 8 professional, Its leadership includes Rajesh Omprakash Sharma (Director), Haresh Hondraj Khetwani (Director). It holds ₹1.30 M open charges and ₹5.23 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 03, Krishna Park,Ahed Arpan School Opp Mansovar, Near Rajdhani Bunglows,Vas, Tral, Ahmedabad, Gujarat, 382449.
U24230GJ2014PTC079996
079996
03 July 2014
₹1.00 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Oncobiotek Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Omprakash Sharma | Director | 03 Jul 2014 | Current |
| Haresh Hondraj Khetwani | Director | 03 Jul 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oncobiotek Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.03% increase. The company also saw a substantial improvement in profitability, with a 181.56% increase in profit. The company's net worth Soared by an impressive increase of 35.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Oncobiotek Drugs had a public holding of 62.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,300,000.00
₹5,225,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2015 | The Bhagyodaya Co-Operative Bank Limited | ₹1.30 M | Open |
| 12 Jul 2017 | Others | ₹1.88 M | Satisfied |
| 12 Jul 2016 | Others | ₹1.00 M | Satisfied |
| 27 Jun 2016 | Others | ₹1.35 M | Satisfied |
| 28 Feb 2015 | The Bhagyodaya Co-Operative Bank Limited | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Oncobiotek Drugs has a workforce of 8 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oncobiotek Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncobiotek Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Oncobiotek Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Oncobiotek Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
The activity A charge registered on 12 Jul 2016 via Charge ID 100039748 with Others was fully satisfied on 12 Jun 2023. was completed.
The activity A charge registered on 27 Jun 2016 via Charge ID 100040433 with Others was fully satisfied on 12 Jun 2023. was completed.
The activity A charge registered on 28 Feb 2015 via Charge ID 10557831 with The Bhagyodaya Co-Operative Bank Limited was fully satisfied on 12 Jun 2023. was completed.
A charge registered on 12 Jul 2017 via Charge ID 100118911 with Others was fully satisfied on 02 Jul 2019. was recorded as a recent event.
The CIN of Oncobiotek Drugs Private Limited is U24230GJ2014PTC079996.
Oncobiotek Drugs Private Limited is headquartered at 03, Krishna Park,Ahed Arpan School Opp Mansovar, Near Rajdhani Bunglows,Vas, Tral, Ahmedabad, Gujarat, 382449.
Oncobiotek Drugs Private Limited was incorporated on 03 July 2014.
The current directors of Oncobiotek Drugs Private Limited are
The primary industry of Oncobiotek Drugs Private Limited is Manufacturing.
Oncobiotek Drugs Private Limited is unlisted.
The authorized capital of Oncobiotek Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Oncobiotek Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX